Search This Blog

Sunday, June 18, 2023

Effect of spaceflight on the human body

American Astronaut Marsha Ivins demonstrates the effects of microgravity on her hair in space

Venturing into the environment of space can have negative effects on the human body. Significant adverse effects of long-term weightlessness include muscle atrophy and deterioration of the skeleton (spaceflight osteopenia). Other significant effects include a slowing of cardiovascular system functions, decreased production of red blood cells (space anemia), balance disorders, eyesight disorders and changes in the immune system. Additional symptoms include fluid redistribution (causing the "moon-face" appearance typical in pictures of astronauts experiencing weightlessness), loss of body mass, nasal congestion, sleep disturbance, and excess flatulence. Overall, NASA refers to the various deleterious effects of spaceflight on the human body by the acronym RIDGE (i.e., "space radiation, isolation and confinement, distance from Earth, gravity fields, and hostile and closed environments").

The engineering problems associated with leaving Earth and developing space propulsion systems have been examined for over a century, and millions of hours of research have been spent on them. In recent years there has been an increase in research on the issue of how humans can survive and work in space for extended and possibly indefinite periods of time. This question requires input from the physical and biological sciences and has now become the greatest challenge (other than funding) facing human space exploration. A fundamental step in overcoming this challenge is trying to understand the effects and impact of long-term space travel on the human body.

In October 2015, the NASA Office of Inspector General issued a health hazards report related to space exploration, including a human mission to Mars.

On 12 April 2019, NASA reported medical results, from the Astronaut Twin Study, where one astronaut twin spent a year in space on the International Space Station, while the other twin spent the year on Earth, which demonstrated several long-lasting changes, including those related to alterations in DNA and cognition, when one twin was compared with the other.

In November 2019, researchers reported that astronauts experienced serious blood flow and clot problems while on board the International Space Station, based on a six-month study of 11 healthy astronauts. The results may influence long-term spaceflight, including a mission to the planet Mars, according to the researchers.

Physiological effects

Many of the environmental conditions experienced by humans during spaceflight are very different from those in which humans evolved; however, technology such as that offered by a spaceship or spacesuit is able to shield people from the harshest conditions. The immediate needs for breathable air and drinkable water are addressed by a life support system, a group of devices that allow human beings to survive in outer space. The life support system supplies air, water and food. It must also maintain temperature and pressure within acceptable limits and deal with the body's waste products. Shielding against harmful external influences such as radiation and micro-meteorites is also necessary.

Some hazards are difficult to mitigate, such as weightlessness, also defined as a microgravity environment. Living in this type of environment impacts the body in three important ways: loss of proprioception, changes in fluid distribution, and deterioration of the musculoskeletal system.

On November 2, 2017, scientists reported that significant changes in the position and structure of the brain have been found in astronauts who have taken trips in space, based on MRI studies. Astronauts who took longer space trips were associated with greater brain changes.

In October 2018, NASA-funded researchers found that lengthy journeys into outer space, including travel to the planet Mars, may substantially damage the gastrointestinal tissues of astronauts. The studies support earlier work that found such journeys could significantly damage the brains of astronauts, and age them prematurely.

In March 2019, NASA reported that latent viruses in humans may be activated during space missions, adding possibly more risk to astronauts in future deep-space missions.

Research

Space medicine is a developing medical practice that studies the health of astronauts living in outer space. The main purpose of this academic pursuit is to discover how well and for how long people can survive the extreme conditions in space, and how fast they can re-adapt to the Earth's environment after returning from space. Space medicine also seeks to develop preventive and palliative measures to ease the suffering caused by living in an environment to which humans are not well adapted.

Ascent and re-entry

During takeoff and re-entry space travelers can experience several times normal gravity. An untrained person can usually withstand about 3g, but can black out at 4 to 6g. G-force in the vertical direction is more difficult to tolerate than a force perpendicular to the spine because blood flows away from the brain and eyes. First the person experiences a temporary loss of vision and then at higher g-forces loses consciousness. G-force training and a G-suit which constricts the body to keep more blood in the head can mitigate the effects. Most spacecraft are designed to keep g-forces within comfortable limits.

Space environments

The environment of space is lethal without appropriate protection: the greatest threat in the vacuum of space derives from the lack of oxygen and pressure, although temperature and radiation also pose risks. The effects of space exposure can result in ebullism, hypoxia, hypocapnia, and decompression sickness. In addition to these, there is also cellular mutation and destruction from high energy photons and sub-atomic particles that are present in the surroundings. Decompression is a serious concern during the extra-vehicular activities (EVAs) of astronauts. Current Extravehicular Mobility Unit (EMU) designs take this and other issues into consideration, and have evolved over time. A key challenge has been the competing interests of increasing astronaut mobility (which is reduced by high-pressure EMUs, analogous to the difficulty of deforming an inflated balloon relative to a deflated one) and minimising decompression risk. Investigators have considered pressurizing a separate head unit to the regular 71 kPa (10.3 psi) cabin pressure as opposed to the current whole-EMU pressure of 29.6 kPa (4.3 psi). In such a design, pressurization of the torso could be achieved mechanically, avoiding mobility reduction associated with pneumatic pressurization.

Vacuum

This 1768 painting, An Experiment on a Bird in the Air Pump by Joseph Wright of Derby, depicts an experiment performed by Robert Boyle in 1660 to test the effect of a vacuum on a living system.

Human physiology is adapted to living within the atmosphere of Earth, and a certain amount of oxygen is required in the air we breathe. If the body does not get enough oxygen, then the astronaut is at risk of becoming unconscious and dying from hypoxia. In the vacuum of space, gas exchange in the lungs continues as normal but results in the removal of all gases, including oxygen, from the bloodstream. After 9 to 12 seconds, the deoxygenated blood reaches the brain, and it results in the loss of consciousness. Exposure to vacuum for up to 30 seconds is unlikely to cause permanent physical damage. Animal experiments show that rapid and complete recovery is normal for exposures shorter than 90 seconds, while longer full-body exposures are fatal and resuscitation has never been successful. There is only a limited amount of data available from human accidents, but it is consistent with animal data. Limbs may be exposed for much longer if breathing is not impaired.

In December 1966, aerospace engineer and test subject Jim LeBlanc of NASA was participating in a test to see how well a pressurized space suit prototype would perform in vacuum conditions. To simulate the effects of space, NASA constructed a massive vacuum chamber from which all air could be pumped. At some point during the test, LeBlanc's pressurization hose became detached from the space suit. Even though this caused his suit pressure to drop from 3.8 psi (26.2 kPa) to 0.1 psi (0.7 kPa) in less than 10 seconds, LeBlanc remained conscious for about 14 seconds before losing consciousness due to hypoxia; the much lower pressure outside the body causes rapid de-oxygenation of the blood. "As I stumbled backwards, I could feel the saliva on my tongue starting to bubble just before I went unconscious and that's the last thing I remember", recalls LeBlanc. A colleague entered the chamber within 25 seconds and gave LeBlanc oxygen. The chamber was repressurized in 1 minute instead of the normal 30 minutes. LeBlanc recovered almost immediately with just an earache and no permanent damage.

Another effect from a vacuum is a condition called ebullism which results from the formation of bubbles in body fluids due to reduced ambient pressure, the steam may bloat the body to twice its normal size and slow circulation, but tissues are elastic and porous enough to prevent rupture. Technically, ebullism is considered to begin at an elevation of around 19 kilometres (12 mi) or pressures less than 6.3 kPa (47 mm Hg), known as the Armstrong limit. Experiments with other animals have revealed an array of symptoms that could also apply to humans. The least severe of these is the freezing of bodily secretions due to evaporative cooling. Severe symptoms, such as loss of oxygen in tissue, followed by circulatory failure and flaccid paralysis would occur in about 30 seconds. The lungs also collapse in this process, but will continue to release water vapour leading to cooling and ice formation in the respiratory tract. A rough estimate is that a human will have about 90 seconds to be recompressed, after which death may be unavoidable. Swelling from ebullism can be reduced by containment in a flight suit which are necessary to prevent ebullism above 19 km. During the Space Shuttle program astronauts wore a fitted elastic garment called a Crew Altitude Protection Suit (CAPS) which prevented ebullism at pressures as low as 2 kPa (15 mm Hg).

The only humans known to have died of exposure to vacuum in space are the three crew-members of the Soyuz 11 spacecraft; Vladislav Volkov, Georgi Dobrovolski, and Viktor Patsayev. During preparations for re-entry from orbit on June 30, 1971, a pressure-equalisation valve in the spacecraft's descent module unexpectedly opened at an altitude of 168 kilometres (551,000 ft), causing rapid depressurisation and the subsequent death of the entire crew.

Temperature

In a vacuum, there is no medium for removing heat from the body by conduction or convection. Loss of heat is by radiation from the 310 K temperature of a person to the 3 K of outer space. This is a slow process, especially in a clothed person, so there is no danger of immediately freezing. Rapid evaporative cooling of skin moisture in a vacuum may create frost, particularly in the mouth, but this is not a significant hazard.

Exposure to the intense radiation of direct, unfiltered sunlight would lead to local heating, though that would likely be well distributed by the body's conductivity and blood circulation. Other solar radiation, particularly ultraviolet rays, however, may cause severe sunburn.

Radiation

Comparison of Radiation Doses – includes the amount detected on the trip from Earth to Mars by the RAD on the MSL (2011–2013).

Without the protection of Earth's atmosphere and magnetosphere astronauts are exposed to high levels of radiation. High levels of radiation damage lymphocytes, cells heavily involved in maintaining the immune system; this damage contributes to the lowered immunity experienced by astronauts. Radiation has also recently been linked to a higher incidence of cataracts in astronauts. Outside the protection of low Earth orbit, galactic cosmic rays present further challenges to human spaceflight, as the health threat from cosmic rays significantly increases the chances of cancer over a decade or more of exposure. A NASA-supported study reported that radiation may harm the brain of astronauts and accelerate the onset of Alzheimer's disease. Solar flare events (though rare) can give a fatal radiation dose in minutes. It is thought that protective shielding and protective drugs may ultimately lower the risks to an acceptable level.

Crew living on the International Space Station (ISS) are partially protected from the space environment by Earth's magnetic field, as the magnetosphere deflects solar wind around the earth and the ISS. Nevertheless, solar flares are powerful enough to warp and penetrate the magnetic defences, and so are still a hazard to the crew. The crew of Expedition 10 took shelter as a precaution in 2005 in a more heavily shielded part of the station designed for this purpose. However, beyond the limited protection of Earth's magnetosphere, interplanetary human missions are much more vulnerable. Lawrence Townsend of the University of Tennessee and others have studied the most powerful solar flare ever recorded. Radiation doses astronauts would receive from a flare of this magnitude could cause acute radiation sickness and possibly even death.

There is scientific concern that extended spaceflight might slow down the body's ability to protect itself against diseases. Radiation can penetrate living tissue and cause both short and long-term damage to the bone marrow stem cells which create the blood and immune systems. In particular, it causes 'chromosomal aberrations' in lymphocytes. As these cells are central to the immune system, any damage weakens the immune system, which means that in addition to increased vulnerability to new exposures, viruses already present in the body—which would normally be suppressed—become active. In space, T-cells (a form of lymphocyte) are less able to reproduce properly, and the T-cells that do reproduce are less able to fight off infection. Over time immunodeficiency results in the rapid spread of infection among crew members, especially in the confined areas of space flight systems.

On 31 May 2013, NASA scientists reported that a possible human mission to Mars may involve a great radiation risk based on the amount of energetic particle radiation detected by the RAD on the Mars Science Laboratory while traveling from the Earth to Mars in 2011–2012.

In September 2017, NASA reported radiation levels on the surface of the planet Mars were temporarily doubled, and were associated with an aurora 25-times brighter than any observed earlier, due to a massive, and unexpected, solar storm in the middle of the month.

Weightlessness

Astronauts on the ISS in weightless conditions. Michael Foale can be seen exercising in the foreground.

Following the advent of space stations that can be inhabited for long periods of time, exposure to weightlessness has been demonstrated to have some deleterious effects on human health. Humans are well-adapted to the physical conditions at the surface of the earth, and so in response to weightlessness, various physiological systems begin to change, and in some cases, atrophy. Though these changes are usually temporary, some do have a long-term impact on human health.

Short-term exposure to microgravity causes space adaptation syndrome, self-limiting nausea caused by derangement of the vestibular system. Long-term exposure causes multiple health problems, one of the most significant being loss of bone and muscle mass. Over time these deconditioning effects can impair astronauts' performance, increase their risk of injury, reduce their aerobic capacity, and slow down their cardiovascular system. As the human body consists mostly of fluids, gravity tends to force them into the lower half of the body, and our bodies have many systems to balance this situation. When released from the pull of gravity, these systems continue to work, causing a general redistribution of fluids into the upper half of the body. This is the cause of the round-faced 'puffiness' seen in astronauts. Redistributing fluids around the body itself causes balance disorders, distorted vision, and a loss of taste and smell.

A 2006 Space Shuttle experiment found that Salmonella typhimurium, a bacterium that can cause food poisoning, became more virulent when cultivated in space. On April 29, 2013, scientists in Rensselaer Polytechnic Institute, funded by NASA, reported that, during spaceflight on the International Space Station, microbes seem to adapt to the space environment in ways "not observed on Earth" and in ways that "can lead to increases in growth and virulence". More recently, in 2017, bacteria were found to be more resistant to antibiotics and to thrive in the near-weightlessness of space. Microorganisms have been observed to survive the vacuum of outer space.

Motion sickness

Bruce McCandless II floating free in orbit with a space suit and Manned Maneuvering Unit.

The most common problem experienced by humans in the initial hours of weightlessness is known as space adaptation syndrome or SAS, commonly referred to as space sickness. It is related to motion sickness, and arises as the vestibular system adapts to weightlessness. Symptoms of SAS include nausea and vomiting, vertigo, headaches, lethargy, and overall malaise. The first case of SAS was reported by cosmonaut Gherman Titov in 1961. Since then, roughly 45% of all people who have flown in space have suffered from this condition.

Bone and muscle deterioration

Aboard the International Space Station, astronaut Frank De Winne is attached to the COLBERT with bungee cords

A major effect of long-term weightlessness involves the loss of bone and muscle mass. Without the effects of gravity, skeletal muscle is no longer required to maintain posture and the muscle groups used in moving around in a weightless environment differ from those required in terrestrial locomotion. In a weightless environment, astronauts put almost no weight on the back muscles or leg muscles used for standing up. Those muscles then start to weaken and eventually get smaller. Consequently, some muscles atrophy rapidly, and without regular exercise astronauts can lose up to 20% of their muscle mass in just 5 to 11 days. The types of muscle fibre prominent in muscles also change. Slow-twitch endurance fibres used to maintain posture are replaced by fast-twitch rapidly contracting fibres that are insufficient for any heavy labour. Advances in research on exercise, hormone supplements, and medication may help maintain muscle and body mass.

Bone metabolism also changes. Normally, bone is laid down in the direction of mechanical stress. However, in a microgravity environment, there is very little mechanical stress. This results in a loss of bone tissue approximately 1.5% per month especially from the lower vertebrae, hip, and femur. Due to microgravity and the decreased load on the bones, there is a rapid increase in bone loss, from 3% cortical bone loss per decade to about 1% every month the body is exposed to microgravity, for an otherwise healthy adult. The rapid change in bone density is dramatic, making bones frail and resulting in symptoms that resemble those of osteoporosis. On Earth, the bones are constantly being shed and regenerated through a well-balanced system which involves signaling of osteoblasts and osteoclasts. These systems are coupled, so that whenever bone is broken down, newly formed layers take its place—neither should happen without the other, in a healthy adult. In space, however, there is an increase in osteoclast activity due to microgravity. This is a problem because osteoclasts break down the bones into minerals that are reabsorbed by the body. Osteoblasts are not consecutively active with the osteoclasts, causing the bone to be constantly diminished with no recovery. This increase in osteoclasts activity has been seen particularly in the pelvic region because this is the region that carries the biggest load with gravity present. A study demonstrated that in healthy mice, osteoclasts appearance increased by 197%, accompanied by a down-regulation of osteoblasts and growth factors that are known to help with the formation of new bone, after only sixteen days of exposure to microgravity. Elevated blood calcium levels from the lost bone result in dangerous calcification of soft tissues and potential kidney stone formation. It is still unknown whether bone recovers completely. Unlike people with osteoporosis, astronauts eventually regain their bone density. After a 3–4 month trip into space, it takes about 2–3 years to regain lost bone density. New techniques are being developed to help astronauts recover faster. Research on diet, exercise, and medication may hold the potential to aid the process of growing new bone.

To prevent some of these adverse physiological effects, the ISS is equipped with two treadmills (including the COLBERT), and the aRED (advanced Resistive Exercise Device), which enable various weight-lifting exercises which add muscle but do nothing for bone density, and a stationary bicycle; each astronaut spends at least two hours per day exercising on the equipment. Astronauts use bungee cords to strap themselves to the treadmill. Astronauts subject to long periods of weightlessness wear pants with elastic bands attached between waistband and cuffs to compress the leg bones and reduce osteopenia.

Currently, NASA is using advanced computational tools to understand how to best counteract the bone and muscle atrophy experienced by astronauts in microgravity environments for prolonged periods of time. The Human Research Program's Human Health Countermeasures Element chartered the Digital Astronaut Project to investigate targeted questions about exercise countermeasure regimes. NASA is focusing on integrating a model of the advanced Resistive Exercise Device (ARED) currently on board the International Space Station with OpenSim musculoskeletal models of humans exercising with the device. The goal of this work is to use inverse dynamics to estimate joint torques and muscle forces resulting from using the ARED, and thus more accurately prescribe exercise regimens for the astronauts. These joint torques and muscle forces could be used in conjunction with more fundamental computational simulations of bone remodeling and muscle adaptation in order to more completely model the end effects of such countermeasures, and determine whether a proposed exercise regime would be sufficient to sustain astronaut musculoskeletal health.

Fluid redistribution

The effects of microgravity on fluid distribution around the body (greatly exaggerated).
 
The Beckman Physiological and Cardiovascular Monitoring System in the Gemini and Apollo suits would inflate and deflate cuffs to stimulate blood flow to lower limbs
 
Astronaut Clayton Anderson observes as a water bubble floats in front of him on the Space Shuttle Discovery. Water cohesion plays a bigger role in microgravity than on Earth

In space, astronauts lose fluid volume—including up to 22% of their blood volume. Because it has less blood to pump, the heart will atrophy. A weakened heart results in low blood pressure and can produce a problem with "orthostatic tolerance", or the body's ability to send enough oxygen to the brain without the astronaut's fainting or becoming dizzy. "Under the effects of the earth's gravity, blood and other body fluids are pulled towards the lower body. When gravity is taken away or reduced during space exploration, the blood tends to collect in the upper body instead, resulting in facial edema and other unwelcome side effects. Upon return to earth, the blood begins to pool in the lower extremities again, resulting in orthostatic hypotension."

Disruption of senses

Vision

In 2013 NASA published a study that found changes to the eyes and eyesight of monkeys with spaceflights longer than 6 months. Noted changes included a flattening of the eyeball and changes to the retina. Space traveler's eye-sight can become blurry after too much time in space. Another effect is known as cosmic ray visual phenomena.

[a] NASA survey of 300 male and female astronauts, about 23 percent of short-flight and 49 percent of long-flight astronauts said they had experienced problems with both near and distance vision during their missions. Again, for some people vision problems persisted for years afterward.

— NASA

Since dust can not settle in zero gravity, small pieces of dead skin or metal can get in the eye, causing irritation and increasing the risk of infection.

Long spaceflights can also alter a space traveler's eye movements (particularly the vestibulo-ocular reflex).

Intracranial pressure

Because weightlessness increases the amount of fluid in the upper part of the body, astronauts experience increased intracranial pressure. This appears to increase pressure on the backs of the eyeballs, affecting their shape and slightly crushing the optic nerve. This effect was noticed in 2012 in a study using MRI scans of astronauts who had returned to Earth following at least one month in space. Such eyesight problems could be a major concern for future deep space flight missions, including a crewed mission to the planet Mars.

If indeed elevated intracranial pressure is the cause, artificial gravity might present one solution, as it would for many human health risks in space. However, such artificial gravitational systems have yet to be proven. More, even with sophisticated artificial gravity, a state of relative microgravity may remain, the risks of which remain unknown. 

Taste

One effect of weightlessness on humans is that some astronauts report a change in their sense of taste when in space. Some astronauts find that their food is bland, others find that their favorite foods no longer taste as good (one who enjoyed coffee disliked the taste so much on a mission that he stopped drinking it after returning to Earth); some astronauts enjoy eating certain foods that they would not normally eat, and some experience no change whatsoever. Multiple tests have not identified the cause, and several theories have been suggested, including food degradation, and psychological changes such as boredom. Astronauts often choose strong-tasting food to combat the loss of taste.

Additional physiological effects

Within one month the human skeleton fully extends in weightlessness, causing height to increase by an inch. After two months, calluses on the bottoms of feet molt and fall off from lack of use, leaving soft new skin. Tops of feet become, by contrast, raw and painfully sensitive, as they rub against the handrails feet are hooked into for stability. Tears cannot be shed while crying, as they stick together into a ball. In microgravity odors quickly permeate the environment, and NASA found in a test that the smell of cream sherry triggered the gag reflex. Various other physical discomforts such as back and abdominal pain are common because of the readjustment to gravity, where in space there was no gravity and these muscles could freely stretch. These may be part of the asthenization syndrome reported by cosmonauts living in space over an extended period of time, but regarded as anecdotal by astronauts. Fatigue, listlessness, and psychosomatic worries are also part of the syndrome. The data is inconclusive; however, the syndrome does appear to exist as a manifestation of the internal and external stress crews in space must face.

Psychological effects

Studies of Russian cosmonauts, such as those on Mir, provide data on the long-term effects of space on the human body.

Research

The psychological effects of living in space have not been clearly analyzed but analogies on Earth do exist, such as Arctic research stations and submarines. The enormous stress on the crew, coupled with the body adapting to other environmental changes, can result in anxiety, insomnia and depression.

Stress

There has been considerable evidence that psychosocial stressors are among the most important impediments to optimal crew morale and performance. Cosmonaut Valery Ryumin, twice Hero of the Soviet Union, quotes this passage from "The Handbook of Hymen" by O. Henry in his autobiographical book about the Salyut 6 mission: "If you want to instigate the art of manslaughter just shut two men up in an eighteen by twenty-foot cabin for a month. Human nature won't stand it."

NASA's interest in psychological stress caused by space travel, initially studied when their crewed missions began, was rekindled when astronauts joined cosmonauts on the Russian space station Mir. Common sources of stress in early American missions included maintaining high performance while under public scrutiny, as well as isolation from peers and family. On the ISS, the latter is still often a cause of stress, such as when NASA Astronaut Daniel Tani's mother died in a car accident, and when Michael Fincke was forced to miss the birth of his second child.

Sleep

The amount and quality of sleep experienced in space is poor due to highly variable light and dark cycles on flight decks and poor illumination during daytime hours in the spacecraft. Even the habit of looking out of the window before retiring can send the wrong messages to the brain, resulting in poor sleep patterns. These disturbances in circadian rhythm have profound effects on the neurobehavioural responses of the crew and aggravate the psychological stresses they already experience. Sleep is disturbed on the ISS regularly due to mission demands, such as the scheduling of incoming or departing space vehicles. Sound levels in the station are unavoidably high because the atmosphere is unable to thermosiphon; fans are required at all times to allow processing of the atmosphere, which would stagnate in the freefall (zero-g) environment. Fifty percent of Space Shuttle astronauts took sleeping pills and still got 2 hours less sleep each night in space than they did on the ground. NASA is researching two areas which may provide the keys to a better night's sleep, as improved sleep decreases fatigue and increases daytime productivity. A variety of methods for combating this phenomenon are constantly under discussion.

Duration of space travel

A study of the longest spaceflight concluded that the first three weeks represent a critical period where attention is adversely affected because of the demand to adjust to the extreme change of environment. While Skylab's three crews remained in space 1, 2, and 3 months respectively, long-term crews on Salyut 6, Salyut 7, and the ISS remain about 5–6 months, while MIR expeditions often lasted longer. The ISS working environment includes further stress caused by living and working in cramped conditions with people from very different cultures who speak different languages. First-generation space stations had crews who spoke a single language, while 2nd and 3rd generation stations have crews from many cultures who speak many languages. The ISS is unique because visitors are not classed automatically into 'host' or 'guest' categories as with previous stations and spacecraft, and may not suffer from feelings of isolation in the same way.

Future use

Space colonization efforts must take into account the effects of space on the human body.

The sum of human experience has resulted in the accumulation of 58 solar years in space and a much better understanding of how the human body adapts. In the future, industrialisation of space and exploration of inner and outer planets will require humans to endure longer and longer periods in space. The majority of current data comes from missions of short duration and so some of the long-term physiological effects of living in space are still unknown. A round trip to Mars with current technology is estimated to involve at least 18 months in transit alone. Knowing how the human body reacts to such time periods in space is a vital part of the preparation for such journeys. On-board medical facilities need to be adequate for coping with any type of trauma or emergency as well as contain a huge variety of diagnostic and medical instruments in order to keep a crew healthy over a long period of time, as these will be the only facilities available on board a spacecraft for coping not only with trauma but also with the adaptive responses of the human body in space.

At the moment only rigorously tested humans have experienced the conditions of space. If off-world colonization someday begins, many types of people will be exposed to these dangers, and the effects on the very young are completely unknown. On October 29, 1998, John Glenn, one of the original Mercury 7, returned to space at the age of 77. His space flight, which lasted 9 days, provided NASA with important information about the effects of space flight on older people. Factors such as nutritional requirements and physical environments which have so far not been examined will become important. Overall, there is little data on the manifold effects of living in space, and this makes attempts toward mitigating the risks during a lengthy space habitation difficult. Testbeds such as the ISS are currently being utilized to research some of these risks.

The environment of space is still largely unknown, and there will likely be as-yet-unknown hazards. Meanwhile, future technologies such as artificial gravity and more complex bioregenerative life support systems may someday be capable of mitigating some risks.

Depersonalization-derealization disorder

Depersonalization-derealization disorder
SpecialtyPsychiatry, clinical psychology
SymptomsDepersonalization, Derealization
Usual onsetYoung adulthood
Durationchronic, episodic
TreatmentPsychotherapy
Frequency1–2% (general population)

Depersonalization-derealization disorder (DPDR, DPD)[3][4] is a mental disorder in which the person has persistent or recurrent feelings of depersonalization and/or derealization. Depersonalization is described as feeling disconnected or detached from one's self. Individuals may report feeling as if they are an outside observer of their own thoughts or body, and often report feeling a loss of control over their thoughts or actions. Derealization is described as detachment from one's surroundings. Individuals experiencing derealization may report perceiving the world around them as foggy, dreamlike/surreal, or visually distorted.

Depersonalization-derealization disorder is thought to be caused largely by interpersonal trauma such as childhood abuse. Adverse early childhood experiences, specifically emotional abuse and neglect have been linked to the development of depersonalization symptoms. Triggers may include significant stress, panic attacks, and drug use. Individuals with the disorder may remain in a depersonalized state for the duration of a typical panic attack. However, in some situations the dissociated state may last for hours, days, or even weeks at a time. In rare cases, symptoms can last for years.

Diagnostic criteria for depersonalization-derealization disorder includes persistent or recurrent feelings of detachment from one's mental or bodily processes or from one's surroundings. A diagnosis is made when the dissociation is persistent and interferes with the social or occupational functions of daily life.

While depersonalization-derealization disorder was once considered rare, lifetime experiences with it occur in about 1–2% of the general population. The chronic form of the disorder has a reported prevalence of 0.8 to 1.9%. While brief episodes of depersonalization or derealization can be common in the general population, the disorder is only diagnosed when these symptoms cause substantial distress or impair social, occupational, or other important areas of functioning.

Signs and symptoms

The core symptoms of depersonalization-derealization disorder are the subjective experience of "unreality in one's self", or detachment from one's surroundings. People who are diagnosed with depersonalization also often experience an urge to question and think critically about the nature of reality and existence.

Individuals with depersonalization describe feeling disconnected from their physicality; feeling as if they are not completely occupying their own body; feeling as if their speech or physical movements are out of their control; feeling detached from their own thoughts or emotions; and experiencing themselves and their lives from a distance. While depersonalization involves detachment from one's self, individuals with derealization feel detached from their surroundings, as if the world around them is foggy, dreamlike, or visually distorted. Individuals with the disorder commonly describe a feeling as though time is passing them by and they are not in the notion of the present. In some cases, individuals may be unable to accept their reflection as their own, or they may have out-of-body experiences. Additionally some individuals experience difficulty concentrating and problems with memory retrieval. These individuals sometimes lack the "feeling" of a memory where they are able to recall a memory but feel as if they did not personally experience it. These experiences which strike at the core of a person's identity and consciousness may cause a person to feel uneasy or anxious. The inner turmoil created by the disorder can also result in depression.

First experiences with depersonalization may be frightening, with patients fearing loss of control, dissociation from the rest of society and functional impairment. The majority of people with depersonalization-derealization disorder misinterpret the symptoms, thinking that they are signs of serious psychosis or brain dysfunction. This commonly leads to an increase of anxiety and obsession, which contributes to the worsening of symptoms.

Factors that tend to diminish symptoms are comforting personal interactions, intense physical or emotional stimulation, and relaxation. Distracting oneself (by engaging in conversation or watching a movie, for example) may also provide temporary relief. Some other factors that are identified as relieving symptom severity are diet or exercise, while alcohol and fatigue are listed by some as worsening their symptoms.

Occasional, brief moments of mild depersonalization can be experienced by many members of the general population; however, depersonalization-derealization disorder occurs when these feelings are strong, severe, persistent, or recurrent and when these feelings interfere with daily functioning. DPDR episodes tend to be transient but duration is highly variable with some lasting as long as several weeks.

A growing number of users participating in virtual reality (VR) are facing the hazard of DPDR with dissociative experiences after use. Higher levels of a lessened sense of reality and being easily immersed can occur.

Causes

The exact cause of depersonalization is unknown, although biopsychosocial correlations and triggers have been identified. It has been thought that depersonalization can be caused by a biological response to dangerous or life-threatening situations which causes heightened senses and emotional numbing.

Psychosocial

There is growing evidence linking physical and sexual abuse in childhood with the development of dissociative disorders. Childhood interpersonal trauma – emotional abuse in particular – is a significant predictor of a diagnosis of DPDR. Compared to other types of childhood trauma, emotional abuse has been found to be the most significant predictor both of a diagnosis of depersonalization disorder and of depersonalization scores, but not of general dissociation scores. Some studies suggest that greater emotional abuse and lower physical abuse predict depersonalization in adult women with post-traumatic stress disorder (PTSD). Patients with high interpersonal abuse histories (HIA) show significantly higher scores on the Cambridge Depersonalization Scale, when compared to a control group. Earlier age of abuse, increased duration and parental abuse tend to correlate with severity of dissociative symptoms. Besides traumatic experiences, other common precipitators of the disorder include severe stress, major depressive disorder, panic attacks, and psychoactive substances. People who live in highly individualistic cultures may be more vulnerable to depersonalization, due to threat hypersensitivity and an external locus of control.

Neurobiology

Animated image showing prefrontal cortex, which is thought to play a role in DPDR

There is converging evidence that the prefrontal cortex may inhibit neural circuits that normally form the basis of emotional experience. In an fMRI study of DPDR patients, emotionally aversive scenes activated the right ventral prefrontal cortex. Participants demonstrated a reduced neural response in emotion-sensitive regions, as well as an increased response in regions associated with emotional regulation. In a similar test of emotional memory, depersonalization disorder patients did not process emotionally salient material in the same way as did healthy controls. In a test of skin conductance responses to unpleasant stimuli, the subjects showed a selective inhibitory mechanism on emotional processing.

Studies are beginning to show that the temporoparietal junction has a role in multisensory integration, embodiment, and self-other distinction. Several studies analyzing brain MRI findings from DPDR patients found decreased cortical thickness in the right middle temporal gyrus, reduction in grey matter volume in the right caudate, thalamus, and occipital gyri, as well as lower white matter integrity in the left temporal and right temporoparietal regions. However, no structural changes in the amygdala were observed.

A PET scan found functional abnormalities in the visual, auditory, and somatosensory cortex, as well as in areas responsible for an integrated body schema.

One study examining EEG readings found frontal alpha wave overactivation and increased theta activity waves in the temporal region of the left hemisphere.

Image showing temporoparietal junction, a portion of the brain also thought to play a role in DPDR

It is unclear whether genetics plays a role; however, there are many neurochemical and hormonal changes in individuals with depersonalization disorder. DPDR may be associated with dysregulation of the hypothalamic-pituitary-adrenal axis, the area of the brain involved in the "fight-or-flight" response. Patients demonstrate abnormal cortisol levels and basal activity. Studies found that patients with DPDR could be distinguished from patients with clinical depression and posttraumatic stress disorder.

The vestibular system may also play a role in DPDR. The vestibular system helps control balance, spatial orientation, motor coordination, but also plays a role in self-awareness. Disruption to this system can potentially cause a feeling of detachment from surroundings. Several studies have shown that patients with peripheral vestibular disease are also more likely to have dissociative symptoms when compared to healthy individuals.

Dissociative symptoms are sometimes described by those with neurological diseases, such as amyotrophic lateral sclerosis, Alzheimer's, multiple sclerosis (MS), etc., that directly affect brain tissue.

Diagnosis

Assessment

Diagnosis is based on the self-reported experiences of the person followed by a clinical assessment. Psychiatric assessment includes a psychiatric history and some form of mental status examination. Since some medical and psychiatric conditions mimic the symptoms of DPDR, clinicians must differentiate between and rule out the following to establish a precise diagnosis: temporal lobe epilepsy, panic disorder, acute stress disorder, schizophrenia, migraine, drug use, brain tumor or lesion. No laboratory test for depersonalization-derealization disorder currently exists. As patients with dissociative disorders likely experienced intense trauma in the past, concomitant dissociative disorders should be considered in patients diagnosed with a stress disorder (i.e. PTSD or acute stress disorder).

The diagnosis of depersonalization disorder can be made with the use of the following interviews and scales:

  • The Structured Clinical Interview for DSM-IV Dissociative Disorders (SCID-D) is widely used, especially in research settings. This interview takes about 30 minutes to 1.5 hours, depending on individual's experiences.
  • The Dissociative Experiences Scale (DES) is a simple, quick, self-administered questionnaire that has been widely used to measure dissociative symptoms. It has been used in hundreds of dissociative studies, and can detect depersonalization and derealization experiences.
  • The Dissociative Disorders Interview Schedule (DDIS) is a highly structured interview which makes DSM-IV diagnoses of somatization disorder, borderline personality disorder and major depressive disorder, as well as all the dissociative disorders. It inquires about positive symptoms of schizophrenia, secondary features of dissociative identity disorder, extrasensory experiences, substance abuse and other items relevant to the dissociative disorders. The DDIS can usually be administered in 30–45 minutes.
  • The Cambridge Depersonalization Scale (CDS) is a method for determining the severity of depersonalization disorder. It has been proven and accepted as a valid tool for the diagnosis of depersonalization disorder in a clinical setting. It is also used in a clinical setting to differentiate minor episodes of depersonalization from actual symptoms of the disorder. Due to the success of the CDS, a group of Japanese researchers underwent the effort to translate the CDS into the J-CDS or the Japanese Cambridge Depersonalization Scale. Through clinical trials, the Japanese research team successfully tested their scale and determined its accuracy. One limitation is that the scale does not allow for the differentiation between past and present episodes of depersonalization. It may be difficult for the individual to describe the duration of a depersonalization episode, and thus the scale may lack accuracy. The project was conducted in the hope that it would stimulate further scientific investigations into depersonalization disorder.

Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5)

In the DSM-5, the word "derealization" was added to "depersonalization disorder" and renamed "depersonalization/derealization disorder" ("DPDR"). It remains classified as a dissociative disorder.

Patients must meet the following criteria to be diagnosed per the DSM-5:

  1. Presence of persistent/recurrent episodes of depersonalization/derealization
  2. Ability to distinguish between reality and dissociation during an episode (i.e. patient is aware of a perceptual disturbance)
  3. Symptoms are severe enough to interfere with social, occupational, or other areas of functioning
  4. Symptoms are not due to a substance or medication
  5. Symptoms are not due to another psychiatric disorder

International Classification of Diseases 11th Revision (ICD-11)

The ICD-11 has relisted DPDR as a disorder rather than a syndrome as previously, and has also reclassified it as a dissociative disorder from its previous listing as a neurotic disorder. The description used in the ICD-11 is similar to the criteria found in the DSM-5. Individuals with DPDR are described as having persistent/recurrent symptoms of depersonalization/derealization, have intact reality testing, and symptoms are not better explained by another psychiatric/neural disorder, substance, medication, or head trauma. Symptoms are severe enough to cause distress or impairment in functioning.

Differential diagnoses

DPDR differentials include neurologic and psychiatric conditions as well as side effects from illicit substances or medications.

Neurologic

Psychiatric

Consequence of psychoactive substance use

Prevention

Depersonalization-derealization disorder may be prevented by connecting children who have been abused with professional mental health help. Some trauma specialists suggest increasing inquiry into information about children's trauma history and exposure to violence, since the majority of people (about 80%) responsible for child maltreatment are the child's own parents. Trauma-specific intervention for children may be useful in preventing future symptoms. Another way to help prevent symptoms is by using "grounding techniques". Grounding techniques involve identifying objects, entities etc... using your five senses. For example, some psychologists recommend identifying five things you can see, four things you can touch, three things you can hear, two things you can smell, and one thing you can taste. Doing this brings the patient 'back to reality' as it helps relieve the anxiety that comes from the 'unknowingness' of one's DPDR.

Treatment

Treatment of DPDR is often difficult and refractory. Some clinicians speculate that this could be due to a delay in diagnosis by which point symptoms tend to be constant and less responsive to treatment. Additionally, symptoms tend to overlap with other diagnoses. Some results have been promising, but are hard to evaluate with confidence due to the small size of trials. However, recognizing and diagnosing the condition may in itself have therapeutic benefits, considering many patients express their problems as baffling and unique to them, but are in fact: one, recognized and described by psychiatry; and two, those affected by it are not the only individuals to be affected from the condition. However, symptoms are often transient and can remit on their own without treatment.

Treatment is primarily non-pharmacological and can include paradoxical intention, record keeping, positive reward, flooding, psychotherapy, cognitive-behavioral therapy, psychoeducation, self-hypnosis, and meditation. Meditation with the focus on the body has been used to achieve self awareness as it allows feelings, which otherwise are put aside or neutralized by the DPDR condition. Self-hypnosis training can be helpful and entails training patients to induce dissociative symptoms and respond in an alternative manner. Psychoeducation involves counseling regarding the disorder, reassurance, and emphasis on DPDR as a perceptual disturbance rather than a true physical experience. Clinical pharmacotherapy research continues to explore a number of possible options, including selective serotonin reuptake inhibitors (SSRI), benzodiazepines, stimulants and opioid antagonists (ex: naltrexone).

Cognitive behavioral therapy

An open study of cognitive behavioral therapy has aimed to help patients reinterpret their symptoms in a nonthreatening way, leading to an improvement on several standardized measures. A standardized treatment for DPDR based on cognitive behavioral principles was published in the Netherlands in 2011.

Medications

Neither antidepressants nor antipsychotics have been found to be useful; additionally, antipsychotics can worsen symptoms of depersonalisation. Tentative evidence supports use of naloxone and naltrexone.

A combination of an SSRI and a benzodiazepine has been proposed to be useful for DPDR patients with anxiety.

Modafinil used alone has been reported to be effective in a subgroup of individuals with depersonalization disorder (those who have attentional impairments, under-arousal and hypersomnia). However, clinical trials have not been conducted.

Repetitive transcranial magnetic stimulation (rTMS)

Some studies have found repetitive transcranial magnetic stimulation (rTMS) to be helpful. One study examined 12 patients with DPDR that were treated with right temporoparietal junction (TPJ) rTMS and found that 50% showed improvement after three weeks of treatment. Five of the participants received an additional three weeks of treatment and reported overall a 68% improvement in their symptoms. Treating patients with rTMS specifically at the TPJ may be an alternative treatment.

Prognosis

DPDR is typically chronic and continuous though some individuals report experiencing periods of remission. Exacerbations can be caused by psychologically stressful situations. Michal et al. (2016) analyzed a 223 case series on patients with DPDR and agreed that the condition tended to be chronic.

Epidemiology

Men and women are diagnosed in equal numbers with depersonalization disorder. A 1991 study on a sample from Winnipeg, Manitoba estimated the prevalence of depersonalization disorder at 2.4% of the population. A 2008 review of several studies estimated the prevalence between 0.8% and 1.9%. This disorder is episodic in about one-third of individuals, with each episode lasting from hours to months at a time. Depersonalization can begin episodically, and later become continuous at constant or varying intensity.

Onset is typically during the teenage years or early 20s, although some report being depersonalized as long as they can remember, and others report a later onset. The onset can be acute or insidious. With acute onset, some individuals remember the exact time and place of their first experience of depersonalization. This may follow a prolonged period of severe stress, a traumatic event, an episode of another mental illness, or drug use. Insidious onset may reach back as far as can be remembered, or it may begin with smaller episodes of lesser severity that become gradually stronger. Patients with drug-induced depersonalization do not appear to be a clinically separate group from those with a non-drug precipitant.

Relation to other psychiatric disorders

Depersonalization exists as both a primary and secondary phenomenon, although making a clinical distinction appears easy, it is not absolute. The most common comorbid disorders are depression and anxiety, although cases of depersonalization disorder without symptoms of either do exist. Comorbid obsessive and compulsive behaviours may exist as attempts to deal with depersonalization, such as checking whether symptoms have changed and avoiding behavioural and cognitive factors that exacerbate symptoms. Many people with personality disorders such as schizoid personality disorder, schizotypal personality disorder, and borderline personality disorder will have high chances of having depersonalization disorder.

History

The word depersonalization itself was first used by Henri Frédéric Amiel in The Journal Intime. The 8 July 1880 entry reads:

I find myself regarding existence as though from beyond the tomb, from another world; all is strange to me; I am, as it were, outside my own body and individuality; I am depersonalized, detached, cut adrift. Is this madness?

Depersonalization was first used as a clinical term by Ludovic Dugas in 1898 to refer to "a state in which there is the feeling or sensation that thoughts and acts elude the self and become strange; there is an alienation of personality – in other words a depersonalization". This description refers to personalization as a psychical synthesis of attribution of states to the self.

Early theories of the cause of depersonalization focused on sensory impairment. Maurice Krishaber proposed depersonalization was the result of pathological changes to the body's sensory modalities which lead to experiences of "self-strangeness" and the description of one patient who "feels that he is no longer himself". One of Carl Wernicke's students suggested all sensations were composed of a sensory component and a related muscular sensation that came from the movement itself and served to guide the sensory apparatus to the stimulus. In depersonalized patients, these two components were not synchronized, and the myogenic sensation failed to reach consciousness. The sensory hypothesis was challenged by others who suggested that patient complaints were being taken too literally and that some descriptions were metaphors – attempts to describe experiences that are difficult to articulate in words. Pierre Janet approached the theory by pointing out his patients with clear sensory pathology did not complain of symptoms of unreality, and that those who have depersonalization were normal from a sensory viewpoint.

Psychodynamic theory formed the basis for the conceptualization of dissociation as a defense mechanism. Within this framework, depersonalization is understood as a defense against a variety of negative feelings, conflicts, or experiences. Sigmund Freud himself experienced fleeting derealization when visiting the Acropolis in person; having read about it for years and knowing it existed, seeing the real thing was overwhelming and proved difficult for him to perceive it as real. Freudian theory is the basis for the description of depersonalization as a dissociative reaction, placed within the category of psychoneurotic disorders, in the first two editions of the Diagnostic and Statistical Manual of Mental Disorders.

Some argue that because depersonalization and derealization are both impairments to one's ability to perceive reality, they are merely two facets of the same disorder. Depersonalization also differs from delusion in the sense that the patient is able to differentiate between reality and the symptoms they may experience. The ability to sense that something is unreal is maintained when experiencing symptoms of the disorder. The problem with properly defining depersonalization also lies within the understanding of what reality actually is. In order to comprehend the nature of reality we must incorporate all the subjective experiences throughout and thus the problem of obtaining an objective definition is brought about again.

Society and culture

Depersonalization disorder has appeared in a variety of media. The director of the autobiographical documentary Tarnation, Jonathan Caouette, had depersonalization disorder. The screenwriter for the 2007 film Numb had depersonalization disorder, as does the film's protagonist played by Matthew Perry. Norwegian painter Edvard Munch's famous masterpiece The Scream may have been inspired by depersonalization disorder. In Glen Hirshberg's novel The Snowman's Children, main female plot characters throughout the book had a condition that is revealed to be depersonalization disorder. Suzanne Segal had an episode in her 20s that was diagnosed by several psychologists as depersonalization disorder, though Segal herself interpreted it through the lens of Buddhism as a spiritual experience, commonly known as "Satori" or "Samadhi". The song "Is Happiness Just a Word?" by hip hop artist Vinnie Paz describes his struggle with depersonalization disorder. Adam Duritz, of the band Counting Crows, has often spoken about his diagnosis of depersonalization disorder.

Lagrangian mechanics

From Wikipedia, the free encyclopedia https://en.wikipedia.org/wiki/Lagrangian_mechanics Joseph-Lo...